A/Prof Aideen McInerney-Leo, University of Queensland, has been awarded new NHMRC Partnership funding for the project titled Melanoma Population Screening: Using Genomics to Facilitate Risk Stratification.
This grant will collaborate with consumers and industry partners to create personalised risk scores based on traditional melanoma risk factors and genetic data.
The personalised risk scores inform people’s surveillance, to improve the early detection of melanoma in individuals at greatest risk. This, in turn, will reduce the burden of the disease on individuals and the health system.
As part of this research, ACEMID participants who provide a genetic saliva sample will be approached to receive personalised risk scores. We will then assess acceptability and impact of providing the results. Health economic analyses will determine the cost effectiveness of risk-stratifying the population.
This project brings together the University of Queensland, QIMR Berghofer, University of Sydney, Monash University, Bioplatforms Australia, Sonic Healthcare, Australian Translational Genomics Centre, Illumina, Melanoma Patients Australia, Melanoma and Skin Cancer Advocacy Network, Canfield Scientific and Metro South Health.
